(Q40156066)

18 September 2017

title

Psoriasis treated with ursodeoxycholic acid: three case reports (English)

1 reference

18 September 2017

Itoh S

1

1 reference

18 September 2017

Kono M

series ordinal

2

1 reference

18 September 2017

Akimoto T

series ordinal

3

1 reference

18 September 2017

publication date

21 March 2007

1 reference

Clinical and Experimental Dermatology

18 September 2017

published in

1 reference

18 September 2017

volume

32

1 reference

18 September 2017

issue

4

1 reference

18 September 2017

page(s)

398-400

1 reference

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02401.X

Combined treatment with ursodeoxycholic acid and pioglitazone in a patient with NASH associated with type 2 diabetes and psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02401.X

Psoriasis and the arachidonic acid cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02401.X

Cloning of a gene for a novel epithelium-specific cytosolic phospholipase A2, cPLA2delta, induced in psoriatic skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02401.X

Effects of long-term ursodeoxycholate administration on expression levels of secretory low-molecular-weight phospholipases A2 and mucin genes in gallbladders and biliary composition in patients with multiple cholesterol stones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02401.X

Suppressive effect of ursodeoxycholic acid on type IIA phospholipase A2 expression in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02401.X

Taurin-conjugated ursodeoxycholic acid has a reversible inhibitory effect on human keratinocyte growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02401.X

10.1111/J.1365-2230.2007.02401.X

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference